Related Experiment Video

Updated: May 28, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

[Clopidogrel and stroke]

Manuel Rodríguez-Yáñez1, Susana Arias-Rivas, José Fernández-Ferro

  • 1Servicio de Neurología, Hospital Clinico de Santiago de Compostela, 15706 Santiago de Compostela, Espana.

Revista De Neurologia
|October 21, 2011
PubMed

Insights

Clopidogrel, an antiplatelet drug, effectively prevents ischemic stroke and vascular events, particularly in high-risk patients. It offers benefits over aspirin due to its unique mechanism and anti-inflammatory properties.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Ischemic stroke remains a leading cause of disability and death in industrialized nations.
  • Antiplatelet therapy, including aspirin, is crucial for reducing vascular event risk.
  • Novel antiplatelet agents like clopidogrel offer alternative mechanisms and potential advantages.

Purpose of the Study:

  • To review studies on clopidogrel's efficacy in preventing ischemic stroke.
  • To compare clopidogrel's effectiveness with aspirin and other antiplatelet strategies.
  • To explore clopidogrel's role in monotherapy and combination treatment.

Main Methods:

  • Review of clinical studies investigating clopidogrel for stroke prevention.
  • Analysis of clopidogrel's mechanism of action, including P2Y12 receptor inhibition.
  • Evaluation of clopidogrel's pleiotropic effects, such as anti-inflammatory actions.

Main Results:

  • Clopidogrel demonstrated superior efficacy over aspirin in preventing vascular events in high-risk populations.
  • The drug inhibits adenosine diphosphate-mediated platelet aggregation.
  • Clopidogrel exhibits beneficial anti-inflammatory effects during ischemic events.

Conclusions:

  • Clopidogrel is a valuable therapeutic option for ischemic stroke prevention.
  • Its efficacy is particularly notable in patients with high cardiovascular risk.
  • Further research supports clopidogrel's use, alone or in combination, for vascular event reduction.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...